Table 4.
Mendelian randomization estimates for the associations between three measures of arsenic metabolism efficiency and asthma-associated traits among those with low inferred rice consumption (n = 10,087).
Metabolite | Ever-smokers | Never-smokers | ||
---|---|---|---|---|
Odds ratio (95%CI) | p-value | Odds ratio (95%CI) | p-value | |
n = 3947 | n = 6140 | |||
Lifetime asthma | ||||
%iAs | 1.07 (0.95–1.21) | 0.2754 | 1.14 (0.92–1.41) | 0.2120 |
%MMA | 1.04 (0.95–1.14) | 0.3960 | 1.10 (0.94–1.28) | 0.2294 |
%DMA | 0.97 (0.92–1.03) | 0.3374 | 0.95 (0.86–1.04) | 0.2215 |
Current asthma | ||||
%iAs | 1.09 (0.93–1.28) | 0.2858 | 0.90 (0.66–1.21) | 0.4808 |
%MMA | 1.06 (0.94–1.19) | 0.3510 | 0.92 (0.73–1.16) | 0.4924 |
%DMA | 0.97 (0.90–1.03) | 0.3152 | 1.05 (0.92–1.20) | 0.4674 |
Past asthma | ||||
%iAs | 1.07 (0.90–1.28) | 0.4509 | 1.06 (0.95–1.18) | 0.3037 |
%MMA | 1.03 (0.91–1.18) | 0.6270 | 1.05 (0.97–1.14) | 0.2178 |
%DMA | 0.98 (0.90–1.06) | 0.5512 | 0.97 (0.93–1.02) | 0.2461 |
FEV1 below LLN | ||||
%iAs | 1.13 (0.99–1.28) | 0.0617 | 0.96 (0.86–1.08) | 0.4976 |
%MMA | 1.10 (1.01–1.21) | 0.0367* | 0.98 (0.90–1.07) | 0.6839 |
%DMA | 0.95 (0.90–1.00) | 0.0414* | 1.01 (0.96–1.07) | 0.6026 |
FVC below LLN | ||||
%iAs | 0.98 (0.85–1.11) | 0.7103 | 0.99 (0.88–1.11) | 0.8596 |
%MMA | 0.98 (0.89–1.08) | 0.6520 | 1.00 (0.92–1.09) | 0.9822 |
%DMA | 1.01 (0.96–1.07) | 0.6773 | 1.00 (0.95–1.05) | 0.9256 |
FEV1/FVC below LLN | ||||
%iAs | 1.13 (0.97–1.32) | 0.1057 | 0.89 (0.75–1.05) | 0.1707 |
%MMA | 1.08 (0.97–1.21) | 0.1515 | 0.93 (0.82–1.06) | 0.2825 |
%DMA | 0.95 (0.89–1.01) | 0.1246 | 1.05 (0.97–1.13) | 0.2388 |
PEF below LLN | ||||
%iAs | 0.98 (0.83–1.16) | 0.8151 | 1.04 (0.88–1.24) | 0.6296 |
%MMA | 1.02 (0.90–1.15) | 0.8038 | 1.01 (0.89–1.14) | 0.9350 |
%DMA | 1.00 (0.93–1.07) | 0.9527 | 0.99 (0.92–1.07) | 0.8244 |
Low inferred consumers of rice are those below the 80th percentile of consumption for grains.
The reported coefficients are interpreted as the expected increase in the odds of the trait for a one percentage point increase in the arsenic metabolite.
LLN Lower limit of normal, FEV1 forced expiratory volume in one second (mL), FVC forced vital capacity (mL), PEF peak expiratory flow (mL/s), %iAs percent of inorganic arsenic, %MMA percent of monomethylarsenate, %DMA percent of dimethylarsinate.